FDA Inspection
Topiderm Inc.Topiderm Inc. – FDA Inspection, Oct 9, 2018
Record Details
This FDA Inspection record concerns Topiderm Inc., with an inspection on October 9, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 6cb0257c-3762-4067-93dd-c562c7ea0500
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1068193
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 211.122(d)Label storage access limited to authorized personnel
- 21 CFR 211.194(d)Laboratory equipment calibration records
- 21 CFR 211.198(a)Reporting of adverse drug experience to FDA
- 21 CFR 211.67(b)Written procedures fail to include
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Topiderm Inc.
9| Date | Classification | Office | Project area |
|---|---|---|---|
| March 7, 2025 | VAI | New York District Office | Drug Quality Assurance |
| January 21, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 15, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 13, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 2, 2013 | VAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
Other documents for Topiderm Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.